Comparison of the effectiveness of varenicline and combination nicotine replacement therapy for smoking cessation in clinical practice

Mayo Clinic Proceedings

Volumn 88, Issue 3, 2013, Pages 226-233

  Brose, Leonie S ^a   West, Robert ^b   Stapleton, John A ^b  

^a National Centre for Smoking Cessation and Training   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; NICOTINE; VARENICLINE;

ADULT; AGE; CLINICAL PRACTICE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCUPATION; PREDICTION; PRESCRIPTION; SMOKING CESSATION; TREATMENT OUTCOME; VALIDATION STUDY;

EID: 84876583091     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mayocp.2012.11.013     Document Type: Conference Paper

References (20)

1. World Health Organization. Tobacco. http://www.who.int/mediacentre/ factsheets/fs339/en/. Accessed August 9, 2012.
2. Department of Health. Local Stop Smoking Services: Service Delivery and Monitoring Guidance 2011/12. London, England: Department of Health; 2011.
3. Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008;(11):CD000146.
4. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2012;(4):CD006103.
5. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2010;(4):CD000031.
6. Brose LS, West R, McDermott MS, Fidler JA, Croghan E, McEwen A. What makes for an effective stop-smoking service? Thorax. 2011;66(10):924-926.
7. Mills EJ, Wu P, Lockhart I, Thorlund K, Puhan M, Ebbert JO. Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: a systematic review and multiple treatment meta-analysis. Ann Med. 2012;44(6):588-597.
8. Stapleton JA, Watson L, Spirling LI, et al. Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness. Addiction. 2008;103(1):146-154. (Pubitemid 350233424)
9. LohWY, Piper ME, Schlam TR, et al. Should all smokers use combination smoking cessation pharmacotherapy? using novel analytic methods to detect differential treatment effects over 8 weeks of pharmacotherapy. Nicotine Tob Res. 2012;14(2):131-141.
10. The NHS Information Centre. Statistics on NHS Stop Smoking Services: England, April 2009 e March 2010. Leeds, England: The Health and Social Care Information Centre; 2010.
11. The NHS Information Centre. Statistics on NHS Stop Smoking Services: England, April 2010 e March 2011. Leeds, England: The Health and Social Care Information Centre; 2011.
12. McLennan D, Barnes H, Noble M, Davies J, Garratt E. The English Indices of Deprivation 2010. London: Department for Communities and Local Government; 2011.
13. West R, Hajek P, Stead L, Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction. 2005;100(3):299-303. (Pubitemid 40363436)
14. Ferguson J, Bauld L, Chesterman J, Judge K. The English smoking treatment services: one-year outcomes. Addiction. 2005; 100(suppl 2):59-69. (Pubitemid 40525071)
15. Stapleton J. Cigarette smoking prevalence, cessation and relapse. Stat Methods Med Res. 1998;7(2):187-203. (Pubitemid 28294004)
16. Kozlowski LT, Porter CQ, Orleans CT, Pope MA, Heatherton T. Predicting smoking cessation with self-reported measures of nicotine dependence: FTQ, FTND, and HSI. Drug Alcohol Depend. 1994;34(3):211-216.
17. Rasbash J, Steele F, Browne WJ, Goldstein H. A User's Guide to MLwiN, v2.10. Bristol, England: University of Bristol, Centre for Multilevel Modelling; 2009.
18. Stapleton JA, West R. A direct method and ICER tables for the estimation of the cost-effectiveness of smoking cessation interventions in general populations: application to a new cytisine trial and other examples. Nicotine Tob Res. 2012;14(4): 463-471.
19. Bolin K, Wilson K, Benhaddi H, et al. Cost-effectiveness of varenicline compared with nicotine patches for smoking cessation: results from four European countries. Eur J Public Health. 2009; 19(6):650-654.
20. Ebbert JO, Burke MV, Hays JT, Hurt RD. Combination treatment with varenicline and nicotine replacement therapy. Nicotine Tob Res. 2009;11(5):572-576.